Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
Janssen,pierre fabre,Merck
['bladder', 'erdafitinib', 'erda ', 'jnjnews']
more #asco23 news: posted first results of its confirmatory phase 3 study of balverda (erdafitinib) in metastatic bladder cancer patients w/ fgfr mutations. the pill extended survival from ~8 to 12 months compared to chemo, a 36% risk reduction. 
Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA and emerging tech in biomedicine. Formerly at Boston Globe and C&EN